Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Neurorecovery

1998 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Owner and operator of is a late-stage biopharmaceutical company. The company focuses on the development of neurological drugs that target inflammatory diseases of the peripheral nerves.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 5100 Poplar Avenue
  • Suite 2904
  • Memphis, TN 38137
  • United States

Neurorecovery Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Neurorecovery‘s full profile, request access.

Request full access to PitchBook

Neurorecovery Executive Team (1)

Name Title Board
Seat
Contact
Info
Landon Miller Co-Founder, President and Chief Executive Officer